CPhI Online is the largest global marketplace in the pharma ingredients industry
CPhI Online Report - Pharma Market Trends 2021
Twelve pharma market trends we anticipate across 2021 for the drug development, manufacturing and outsourcing sectors.
2020 has been one of the most turbulent years in recent history and has cast a shroud of uncertainty over the future. While pharmaceutical companies have proved instrumental in responding to the pandemic through innovation, collaboration and manufacturing expertise, COVID-19 has also raised fresh challenges for the industry to overcome.
In this trend report, we explore the key opportunities, disruptors and dynamics which the industry will face throughout 2021.
Pharma’s response to the pandemic in terms of vaccines development and distribution of treatments has grabbed the majority of the headlines but the major issues facing the industry are by no means exclusively coronavirus related.
In interviews with key industry experts, this report identifies key trends that we anticipate throughout 2021, as pharmaceutical manufacturing and outsourcing continue to respond not only to the challenges that the ongoing global crisis has presented, but also to evolving obstacles and hurdles that are typical in such a highly-regulated sector.
Key pharma market trends for 2021:
- Supply chain resilience to take precedence over reshoring of active pharmaceutical ingredient manufacturing
- Pandemic accelerates digital transformation of API sourcing and trading
- Suppy chain security and patient centricity focus
- Cure vs. treatment model shifts CDMO contracts from volume to value
- A gradual breakthrough for continuous manufacturing of APIs
- COVID-19 vaccines to take central stage
- Vaccine distribution and roll-out
- Industry fight against antimicrobial resistance to gain prominence
- Enablers of precision medicine: next-generation sequencing
- Continuing consolidation in the pharma contract services sector
- Emerging pharma markets will be key to expansion of pharma and biopharma capabilities
- Rise in biosimilar applications due to patent expiries
Click the link at the bottom of this page to download the complete CPhI Pharma 2021 Trends Report
SK's financial backing enables CBM to address significant capacity constraints in the cell and gene therapy manufacturing space
The expansion includes the installation of a pilot suite with a 50-L fermenter and automation upgrades to accelerate clinical and commercial projects
The first-of-its-kind centre will offer biopharma clients convenience and efficiencies in the rapidly expanding Northeast
The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPhI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market
Expected increase in approvals for gene therapies, gene-modified cell therapies and recombinant vector vaccines will also increase pressure on manufacturers to build new capacity
Upcoming Late Stage Bioprocessing & Viral Vectors Digital Week running 2-11 November will address many goals and challenges associated with optimizing biologics manufacturing through different stages of the process
Clients to receive accelerated quality testing and reduced turnaround times
By completion at the end of 2022, the campus will accommodate 18 cGMP viral vector manufacturing suites
Position your company at the heart of the global Pharma industry with a CPhI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPhI events
An easy-to-use platform with a detailed dashboard showing your leads and performance